相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in Small-Cell Lung Cancer (SCLC) Translational Research
Benjamin J. Drapkin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Carl M. Gay et al.
CANCER CELL (2021)
MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells
Masayuki Hagiwara et al.
CANCER RESEARCH (2021)
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
Joseph M. Chan et al.
CANCER CELL (2021)
Small-cell lung cancer
Charles M. Rudin et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
Nami Yamashita et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
Anish Thomas et al.
CANCER CELL (2021)
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
Yota Yasumizu et al.
NATURE COMMUNICATIONS (2020)
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
Abbie S. Ireland et al.
CANCER CELL (2020)
Lineage plasticity in cancer: a shared pathway of therapeutic resistance
Alvaro Quintanal-Villalonga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment
Donald W. Kufe
CARCINOGENESIS (2020)
Smoking-associated increase in mucins 1 and 4 in human airways
Heta Merikallio et al.
RESPIRATORY RESEARCH (2020)
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer
C. Allison Stewart et al.
NATURE CANCER (2020)
MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells
Masaaki Yamamoto et al.
CANCER RESEARCH (2019)
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells
Tsuyoshi Hata et al.
CANCER RESEARCH (2019)
Targeting DNA Replication Stress and DNA Double-Strand Break Repair for Optimizing SCLC Treatment
Xing Bian et al.
CANCERS (2019)
Rare Pulmonary Neuroendocrine Cells Are Stem Cells Regulated by Rb, p53, and Notch
Youcef Ouadah et al.
CELL (2019)
Triggering mitosis
Adrijana Crncec et al.
FEBS LETTERS (2019)
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The broken cycle: E2F dysfunction in cancer
Lindsey N. Kent et al.
NATURE REVIEWS CANCER (2019)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M. Rudin et al.
NATURE REVIEWS CANCER (2019)
Recovering Gene Interactions from Single-Cell Data Using Data Diffusion
David van Dijk et al.
CELL (2018)
Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
Rhamy Zeid et al.
NATURE GENETICS (2018)
Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer
Yejing Ge et al.
NATURE REVIEWS GENETICS (2018)
MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells
Hasan Rajabi et al.
ONCOGENE (2018)
Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell Phenotype
Daniel J. McGrail et al.
CELL REPORTS (2018)
Replication stress response in cancer stem cells as a target for chemotherapy
Gwenola Manic et al.
SEMINARS IN CANCER BIOLOGY (2018)
Targeting the human MUC1-C oncoprotein with an antibody-drug conjugate
Govind Panchamoorthy et al.
JCI INSIGHT (2018)
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Jennifer L. Bishop et al.
CANCER DISCOVERY (2017)
Hey Factors at the Crossroad of Tumorigenesis and Clinical Therapeutic Modulation of Hey for Anticancer Treatment
Zihao Liu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
SCENIC: single-cell regulatory network inference and clustering
Sara Aibar et al.
NATURE METHODS (2017)
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu et al.
CANCER CELL (2017)
Small cell lung cancer: Time to revisit DNA-damaging chemotherapy
Anish Thomas et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer
Liyan Jiang et al.
PLOS GENETICS (2016)
Myc and cell cycle control
Gabriel Bretones et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation
Masanori Hasegawa et al.
CLINICAL CANCER RESEARCH (2015)
Spatial reconstruction of single-cell gene expression data
Rahul Satija et al.
NATURE BIOTECHNOLOGY (2015)
Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles
Huayang Liu et al.
NATURE CELL BIOLOGY (2015)
Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target
Deepak Raina et al.
PLOS ONE (2015)
Revisiting Global Gene Expression Analysis
Jakob Loven et al.
CELL (2012)
Dependence on the MUC1-C Oncoprotein in Non-Small Cell Lung Cancer Cells
Deepak Raina et al.
MOLECULAR CANCER THERAPEUTICS (2011)
MUC1 oncoprotein is a druggable target in human prostate cancer cells
Maya Datt Joshi et al.
MOLECULAR CANCER THERAPEUTICS (2009)
分享论文
